THERMAL-XR(R) Sales in the United States to Commence After GMG Receives U.S. EPA Approval

Brisbane, Australia--(ACN Newswire via SeaPRwire.com. - March 16, 2026) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that the United States Environmental Protection Agency ("EPA") has now approved the import and sale of GMG's THERMAL-XR graphene based coating system in the United States.The EPA has issued a consent order for pre-manufacture notice PMN P-25-0018 in accordance with section 5(e) of the Toxic Substances Control Act, 15 U.S.C. 2604(e) (the "Order"). Under the Order, GMG is authorised to export, distribute, sell, use and dispose of the chemical substance described in the pre-manufacture notice submitted by the Company, and which is used in GMG's THERMAL-XR® ENHANCE graphene-based coating system for various applications including Heating Venting Air Conditioning and Refrigeration (HVAC-R), Data Centres, Liquified Natural Gas Plants (LNG), Automotive and Electronics amongst others in the United States in accordance with the requirements and conditions set out in the Order (the "New Chemical Substance").GMG supplies its THERMAL-XR® graphene coating product for the HVAC-R equipment market to its exclusive North American distributor, Nu-Calgon Wholesaler, Inc. ("Nu-Calgon") which is marketed and sold as "Nu-Calgon CoolWorx® powered by GMG® Graphene" as seen in an example shown in Figure 1. As a result of the Order, GMG, together with Nu-Calgon, is now able to commence commercial sales of THERMAL-XR® products into the U.S. for industrial use, subject to and in accordance with the requirements and conditions of the Order.Figure 1: Nu-Calgon CoolWorx® Powered by GMG® Graphene LabelTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/288616_ab987720443d2967_001full.jpgThe first shipment of THERMAL-XR® will now be sent to Nu-Calgon for distribution in North America.Craig Nicol, CEO & Managing Director of the Company, commented, "We believe that this EPA consent order is a major milestone for GMG as it allows us, together with our exclusive North American distributor Nu-Calgon, to commence commercial sales of THERMAL-XR® in we what we see as the largest HVAC-R coating market in the world."Jack Perkowski, Chairman and Non-Executive Director of the Company, commented: "With regulatory clearance now in place, we believe that we can begin converting the strong interest that we have seen from customers into revenue, while leveraging Nu-Calgon's extensive distribution network to reach across the North America to scale THERMAL-XR® ENHANCE / CoolWorx® deployment over time. We believe that GMG is one of the few companies to have received EPA approval for the export and sale of an unlimited amount of a graphene-based product in the United States of America."About THERMAL-XR® ENHANCE powered by GMG Graphene:THERMAL-XR® ENHANCE coating system is a unique method of improving the conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR® ENHANCE is now patented for 20 years in Australia and is expected to be patented in other countries around the world.THERMAL-XR® ENHANCE Development and EPA Approval HistoryMonthSignificant Milestones for THERMAL-XR® powered by GMG GrapheneSeptember2022GMG acquires THERMAL-XR® manufacturing intellectual property and brand rights GMG ACQUIRES THERMAL-XR MANUFACTURING INTELLECTUAL PROPERTY AND BRAND RIGHTS AND GRANTS RSUs TO DIRECTORS AND OFFICERS - Graphene Manufacturing Group | GMG (graphenemg.com)December2022Verified Improved Heat Transfer by The University of Queensland. VERIFIED IMPROVED HEAT TRANSFER ON ALUMINIUM WITH THERMAL-XR® & MARKET UPDATE - Graphene Manufacturing Group | GMG (graphenemg.com)February2023Approval from Australian Industrial Chemicals Introduction Scheme (AICIS) GMG RECEIVES REGULATORY APPROVAL TO ENABLE SIGNIFICANT COMMERCIAL SALES - Graphene Manufacturing Group | GMG (graphenemg.com)April 2023Total available market for THERMAL-XR® estimated by Company to be > US$28.4 billion GMG ANNOUNCES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)April 2023First order of THERMAL-XR® > $120,000 GMG ANNOUNCES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)May 2023Signing of Distributors for Singapore, Thailand, Indonesia & South Korea GMG SIGNS THERMAL-XR® DISTRIBUTOR AGREEMENTS IN 4 ASIAN COUNTRIES - Graphene Manufacturing Group | GMG (graphenemg.com)June 2023Independently Verified Heat Transfer & Energy Savings GMG ANNOUNCES INDEPENDENTLY VERIFIED HEAT TRANSFER AND ENERGY SAVINGS RESULTS FROM THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)July 2023Signing of Nu-Calgon Distribution for North America - USA, Canada, Mexico, & Caribbean. GMG APPOINTS NU-CALGON AS THERMAL-XR® DISTRIBUTOR FOR NORTH AMERICA - Graphene Manufacturing Group | GMG (graphenemg.com)August2023Commissioning of THERMAL-XR® Coating Bulk Blend Plant GMG PROVIDES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)October2023Forward Orders > AU$ 400k - Conditional on Import Approvals for some Countries GMG PROVIDES COMMERCIALISATION UPDATE ON ENERGY SAVINGS COATING THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)December2023Commissioning of the modular Graphene Production plant Graphene Manufacturing Group Commissions Modular Graphene Production Plant - Graphene Manufacturing Group | GMG (graphenemg.com)January2024Canada Approval Department of Environment and Climate Change Canada (ECCC)January2024Launch of Nu-Calgon CoolWorx® powered by GMG Graphene at Chicago AHR Expo 2024. Launch of Nu-Calgon CoolWorx® powered by GMG Graphene at Chicago AHR Expo 2024.April 2024GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR® GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR®December2024GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR® GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR®December2025USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR® USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR® About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information, please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, GMG and Nu-Calgon's ability to leverage Nu-Calgon's distribution network to commence commercial sales of THERMAL-XR® ENHANCE-based products into the U.S. HVAC-R aftermarket, intentions as to the first shipment of THERMAL-XR® ENHANCE, the intended focus of initial THERMAL-XR® ENHANCE deployment, the energy efficiency, decarbonisation and corrosion protection benefits of THERMAL-XR® ENHANCE, GMG's intention to work with the EPA and GMG's intention to progress its broader THERMAL-XR® ENHANCE commercialisation activities.Such forward-looking statements are based on a number of assumptions of management, including the receipt of a fully signed consent notice from the EPA. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288616 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hello IP Reshapes Content Marketing Through a Creator-Driven Distribution Model

The Singapore-headquartered platform helps brands improve content reach and conversion in the era of short-form video and interest-based e-commerce. SINGAPORE – March 16, 2026 – (SeaPRwire) – As short-form video continues to reshape how information spreads and how consumers engage with brands, efficient collaboration between brands and creators has become increasingly important. Hello IP was built to address this need. Hello IP is a content distribution platform focused on social and interest-based e-commerce. By enabling brands to upload ready-made video content and distribute it through local creators across social platforms, Hello IP helps reduce the complexity of traditional creator collaborations, improve campaign efficiency, and create more sustainable monetization opportunities for creators. Under traditional creator marketing models, brands often face lengthy workflows that include influencer sourcing, repeated negotiation, contract signing, sample shipping, content review, and payment settlement. These processes can be slow, costly, and difficult to manage, especially in cross-border campaigns where shipping risks, inconsistent content quality, and uncertain outcomes remain common challenges. Hello IP offers a more efficient alternative. After brands upload content to the platform, creators can select tasks that match their style, audience, and interests, then distribute that content through their own channels. This model helps brands gain more localized and authentic exposure while allowing creators to earn performance-based rewards. To support faster market expansion, Hello IP has developed its core distribution system, Viral Engine, which combines creator distribution, influencer collaboration, advertising support, and cross-market strategies. The platform is currently active in mature TikTok e-commerce markets across Southeast Asia, the United Kingdom, and the United States, with content able to reach targeted creator communities in as little as 24 hours. For creators, Hello IP provides access to daily brand campaigns across categories such as beauty, mobile apps, e-commerce, and gaming. By lowering collaboration barriers and simplifying campaign participation, the platform helps creators unlock more stable income opportunities and build long-term commercial value. Mao Jianfeng, Founder of Hello IP, said, “In today’s creator economy, brands need content distribution models that are more efficient, scalable, and closely connected to local markets. Hello IP aims to build a smoother connection between brands and creators so that both sides can grow together.” As digital marketing enters a new phase, Hello IP’s connector model is creating a more efficient and inclusive path forward for the content ecosystem. About Hello IP Hello IP is one of ET CUBE’s core business pillars in the creator economy, focused on content distribution for social and interest-based e-commerce. Headquartered in Singapore, the platform connects brand content with local creator networks to help brands achieve faster, more authentic distribution and stronger conversion opportunities across key international markets. Media Contact Brand Name: Hello IP Website: https://www.helloipmcn.com

正大企業國際擬更名為正大生物 生物科技業務已成核心增長引擎 以創新和科研打造多元產品矩陣

EQS via SeaPRwire.com / 2026-03-16 / 19:20 UTC+8 正大企業國際擬更名為正大生物 生物科技業務已成核心增長引擎 以創新和科研打造多元產品矩陣   (2026年3月16日 – 香港)正大企業國際有限公司(股份代號:03839.HK)今日欣然宣佈,擬更名為「正大生物控股有限公司」(CPBIO Holding Company Limited)(以下簡稱     「正大生物」或「本公司」)。此次更名計劃旨在更精準體現本公司目前的主營業務及未來的戰略佈局,進一步強化本公司致力成為世界領先的生物科技公司的願景。我們將以「正大生物」之名,繼續攜手全球夥伴,共推生物科技產業的可持續發展。有關建議更名事項尚待股東大會審議通過及百慕大公司註冊處批準。   業務聚焦:生物科技貢獻全部收入,繼續成為核心增長引擎 此次更名計劃是正大生物發展歷程中的重要里程碑,精準反映本公司目前的收入全部來自 生物科技業務(動保獸藥及金黴素產品)。未來,本公司將聚焦合成生物學、生物製品等前沿領域,以生物科技為核心驅動力,持續推動業務增長與行業可持續發展。   核心領域:以科研、創新及國際化為基礎,把握全球畜牧業升級與生物安全趨勢 正大生物立足於生命科學前沿,已實現向全球生物科技解決方案提供商的深度跨越。隨著全球畜牧業向規模化、集約化與生物安全防控加速發展,市場對高效、安全的動保產品需求日益增長。我們將以此為契機,持續加強產品研發與技術創新,在不斷拓展廣闊國際市場的同時,與全球行業夥伴深化合作,以扎實的生物技術構建穩健的業務基礎。   企業精神:踐行願景與使命,成為世界領先的生物科技公司 在以「正大生物」之名開啟新篇章之際,我們更加堅定地傳承並弘揚深植於心的企業精神。正大生物始終秉持“成為世界領先的生物科技公司”這一宏偉願景,並以此引領各項業務的高質量發展。在這一願景下,我們矢志不渝地履行企業使命 - 以創新的生物技術,健康動物,保護地球,造福人類。這份初心不僅是過去成功的基石,也將是未來驅動生物科技創新與應用的核心動力。   未來展望:前沿生物製品 及 合成生物技術 + AI賦能打造跨越週期的增長矩陣 正大生物將啟動新的核心發展引擎:在夯實並升級核心生命健康底盤、深化全球資源協同與市場網絡的基礎上,公司將強力突破前沿創新生物製品的技術壁壘,並戰略性規劃高增長的寵物健康消費賽道;同時,我們將以尖端合成生物技術為產業鏈底層賦能,並全面構建AI與數據驅動的智慧化生態。新的發展引擎將互為協同,共同構築具備強大穿越週期能力的多元化生物科技矩陣,為行業提供更系統、更深度的專業支撐,為股東、客戶及合作夥伴創造長期、可持續的價值。 – 完 –     關於正大企業國際有限公司 正大企業國際有限公司(「正大企業國際」)(股份代號:03839.HK)2015年7月於香港聯交所主板上市,業務包括生物科技業務及投資業務,並於中國的生物科技業界中建立強大的領導地位。   正大企業國際是卜蜂食品企業有限公司(大眾)(股份代號:CPF.TB,簡稱「CPF」)的子公司。CPF是全球領先的農牧食品公司, 並於泰國證券交易所上市。   此新聞稿由金通策略有限公司代正大企業國際有限公司發佈。 如有查詢,請聯絡: DLK Advisory 金通策略 電話:+852 2857 7101  傳真:+852 2857 7103     2026-03-16 此財經新聞稿由EQS via SeaPRwire.com轉載。本公告內容由發行人全權負責。瀏覽原文: http://www.todayir.com/tc/index.php

FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its first set of full-year results as a Hong Kong listed company for the 12 months ended 31 December 2025.- New business sales were up 25 per cent to US$2.446 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) was US$1.476 billion, with year-on-year growth of 18 per cent.- Operating profit after tax was up five per cent to US$499 million with positive contributions from each of the company’s four geographic reporting segments – Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$166 million is a record IFRS 17 result and for the second consecutive year, FWD Group was operating cash flow positive as at 31 December 2025. Leverage ratio reduced to 21.3 per cent approaching the company’s target range of 15-20 per cent.- Significantly increased important indicators of shareholder value creation, with comprehensive tangible equity (CTE) up 18 per cent to US$8.72 billion compared to 31 December 2024 and Group embedded value (EV) up 19 per cent year-on-year to US$6.85 billion. A strong capital position was maintained with a 265 per cent solvency ratio^.- In December 2025, FWD Group was added to the Hang Seng Composite Index and the eligible securities list for the Stock Connect programme, where Mainland Chinese investors connect via the Shanghai Stock Exchange and Shenzhen Stock Exchange with Hong Kong market opportunities via a southbound trading mechanism. FWD Group was also included in the MSCI Hong Kong Small Cap Index in February 2026.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “2025 was a stand-out year for FWD Group. We successfully executed our customer-led strategy, underpinned by our digitally enabled business model. Record financial results were achieved. And of course, we began trading as a publicly listed company, following our July 2025 initial public offering. This fulfilled a long-held objective to ensure FWD Group has full capital market access, as a solid foundation for our future development and growth.”The strong 2025 results were driven by organic growth across most of the 10 Asian markets where FWD Group operates, with a particularly outstanding performance in the Hong Kong SAR & Macau SAR segment.A solid performance was posted in Japan, in a year where FWD began to diversify beyond its successful protection business into the retirement and savings segment, with its first offering – a yen-denominated single premium variable annuity product.As an established market leader in Thailand, FWD remains well positioned to grow quality new business in future, despite headwinds from a lower rate environment which impacted 2025 results, in addition to the 2024 exit from underwriting new business in the corporate care segment.Excellent growth was delivered in the Emerging Markets segment – which is comprised of five of the rest of FWD Group’s Southeast Asian markets – consistent with the longer-term demographic, wealth creation, and digital adoption trends in this region.“With 2026 already underway, we remain firmly focused on executing our strategy as we build for the future – operating with customers at the heart of everything we do in high-growth Asian markets, with a focus on long-term sustainability and profitability,” added Huynh Thanh Phong.About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves more than 38 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828.For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings LimitedThe results are for the 12 months ended 31 December 2025 and are compared to the same period in 2024.Group LCSM cover ratio, group embedded value, comprehensive tangible equity values are December 2025 balances/ratios and growth rates are represented accordingly.Growth rates are represented on a constant exchange rate (CER) basis, unless otherwise stated.Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Comprehensive tangible equity is calculated as total equity of the Group attributable to shareholders of the Company plus contractual service margin (net of tax and non-controlling interests), minus intangible assets (net of non-controlling interests).* Actual exchange rate basis  ^ Prescribed capital requirement (PCR) basis Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category)

TOKYO, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy Japan Ltd. has been recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) under the recognition program, jointly administered by Japan’s Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi (Japan Health Council).Since 2023, the company has been recognized in the Small and Medium‑Sized Enterprise Category for three consecutive years. In 2026, Hitachi Energy in Japan was recognized for the first time in the Large Enterprise Category, reflecting its workforce growth. Organizations certified in this category are expected to lead by example, extending health and productivity management beyond their own operations to group companies, business partners, local communities, customers, and employees’ familiesPeople‑Centric HSE as a Foundation for the Energy TransitionAt Hitachi Energy, we promote “Health and Productivity Management”—activities designed to maintain and enhance employee health—guided by the Hitachi Group Safety and Health Policy, whose core principle is that safety and health always come first, and our global HSE*1 policy, which focuses on improving health and well‑being in the workplace.*1 Health, Safety, and Environment.With people at the heart of everything we do, Hitachi Energy views health and productivity management as a management foundation that underpins corporate value and social trust. By fostering a safe and healthy work environment through shared responsibility and continuous improvement, the company reinforces its role in advancing the energy transition and shaping a sustainable energy future for all.About the Health & Productivity Management Outstanding Organization Recognition ProgramThe Health & Productivity Management Outstanding Organization Recognition Program is a program established by Japan’s Ministry of Economy, Trade and Industry (METI) in fiscal year 2016. The program highlights large enterprises and small and medium‑sized enterprises that are implementing particularly excellent health and productivity management, and aims to develop an environment in which such organizations can gain enhanced recognition from employees, job seekers, related companies, and financial institutions. Marking its 10th year, the 2026 program recognized 3,765 organizations in the Large Enterprise Category and 23,085 organizations in the Small and Medium‑Sized Enterprise Category.ReferenceNippon Kenko Kaigi (Japan Health Council) – Official Website (Japanese)ACTION! Health & Productivity Management – Portal SiteAbout Hitachi EnergyHitachi Energy is a global technology leader in electrification, powering a sustainable energy future with innovative power grid technologies with digital at the core. Over three billion people depend on our technologies to power their daily lives. With over a century in pioneering mission-critical technologies like high-voltage, transformers, automation, and power electronics, we are addressing the most urgent energy challenge of our time – balancing soaring electricity demand, while decarbonizing the power system. With an unparalleled installed base in over 140 countries, we co-create and build long-term partnerships across the utility, industry, transportation, data centers, and infrastructure sectors. Headquartered in Switzerland, we employ over 50,000 people in 60 countries and generate revenues of around $16 billion USD.https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergyAbout Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Bonus Savings Account: What It Is and How It Helps You Earn More Interest

SINGAPORE, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) - In a world where living costs continue to rise, making your money work harder for you is a necessity. While a standard savings account offers a base interest rate, a bonus savings account allows you to earn higher interest by meeting specific conditions.By understanding the mechanics of these accounts, you can turn your idle cash into a productive asset. This article explores the features of these accounts and how they can help you reach your financial goals sooner.What is a Bonus Savings Account?A bonus savings account is a type of bank account that rewards you with higher interest rates when you meet specific conditions. Unlike a basic account that pays a flat, low rate regardless of your activity, these accounts are designed to encourage healthy financial habits.Generally, your total interest is split into two parts: base interest and bonus interest. The base interest is what you earn on every dollar, regardless of your activity. The bonus interest is an additional percentage added when you fulfil certain requirements, such as increasing your monthly balance or spending on a linked credit card.How a Bonus Savings Account Helps You Earn MoreThe primary appeal of a bonus savings account is the ability to earn interest rates that are often several times higher than standard savings accounts. Here is how they help you maximise your earnings:1. Rewarding Consistent Savers: Many accounts reward you for not spending your money. For example, some accounts offer bonus interest if your monthly average balance increases compared to the previous month. This encourages you to keep your funds in the account rather than withdrawing them for impulsive purchases, allowing compounding to work in your favour.2. Consolidating Your Financial Activities: Banks often use a bonus savings account to reward loyalty. You might earn extra interest by linking your salary credit or meeting a minimum spend on the bank's credit cards. By centring your financial activities around one account, you can unlock higher tiers of interest than with a basic savings plan.3. Tiered Interest Structures: Most bonus accounts use a tiered system. This means that as your balance grows, the interest rate on specific brackets of your funds increases. This structure is particularly beneficial for those with growing savings, as it allows larger balances to earn higher rates.Common Requirements to Unlock Bonus InterestTo make the most of a bonus savings account, you need to understand the typical requirements. Banks in Singapore usually look for the following:Balance Growth: Maintaining or increasing your balance month on month.Salary Credit: Having your monthly take-home pay credited directly into the account via your employer.Spend Requirements: Using a linked debit or credit card for a minimum amount (often SGD 500) each month.Investing or Insuring: Purchasing eligible insurance or investment products through the bank.Is a Bonus Savings Account Right for You?While the high interest rates are attractive, a bonus savings account is most effective when it aligns with your natural spending and saving habits.If you are someone who saves a portion of your income every month and rarely withdraws from your reserves, an account that rewards balance growth is an excellent fit. However, if you prefer an account that doesn't require you to track credit card spending or investment tiers, you may want to consider a simpler savings account.Strategies to Maximise Your InterestTo ensure you never miss out on your bonus interest, consider these simple steps:Automate Your Savings: Set up a standing instruction to move a fixed amount into your bonus savings account every month. This ensures your balance grows consistently without you having to remember to do it manually.Track Your Monthly Average Balance: Be mindful of the mid-month balance rather than just the balance on the last day of the month. Large withdrawals in the middle of the month may lower your average balance.Consolidate Spending: If your account requires a minimum card spend, try to put all your essential costs, such as groceries, transport, and utilities, on that specific card to hit the target easily.Final ThoughtsA bonus savings account can be a useful tool for improving returns on your cash savings. It transforms the act of saving from a passive habit into a rewarding strategy. By choosing an account that fits your lifestyle and staying disciplined with the requirements, you can help your hard-earned money grow at a higher rate.Disclaimer: This article is for general information only and does not have any regard to the specific investment objectives, financial situation and particular needs of any specific person. The views expressed in this article are solely those of the author. This article shall not be regarded as an offer, recommendation, solicitation or advice. You may wish to consult your own professional advisers about this article, in particular, a financial professional before making financial decisions. Any past events, trends and/or performance referred to in this article may not necessarily be indicative of future events, trends or performance. This article is based on certain assumptions and reflects prevailing conditions as at the time of publication, which are subject to change at any time without notice. The author and publisher of this article as well as any other parties associated with this article make no representation or warranty of any kind, whether express, implied or statutory, in respect of this article and accept no liability or responsibility for the completeness or accuracy of this article or any error, inaccuracy or omission relating to this article and/or any consequence, injury, loss or damage howsoever suffered by any person relating to this article, in particular, arising from any reliance by any person on this article. Publishers or platforms may be compensated for access to third party websites.Contact Information:Name : Sonakshi MurzeEmail : Sonakshi.murze@iquanti.comJob Title : ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China

SHENZHEN, CHINA, Mar 13, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients. The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance. More information about Desidustat Tablets and Renal Anaemia As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders. There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia. Desidustat Tablets have been approved for marketing in India. CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020. The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference 1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6 2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015 3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025) 4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012 CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

China Lilang Announces 2025 Annual Results

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – China Lilang Limited (“China Lilang” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1234) today announced its results for the year 2025.Mr. Wang Dong Xing, Chairman and Non-Executive Director of China Lilang, said: “In 2025, against a backdrop of steady macroeconomic recovery and moderate growth in the consumer market, the apparel industry in the Chinese Mainland maintained an overall stable development trajectory despite facing pressure. Amid the broader trend of consumption upgrading, the menswear market is undergoing structural differentiation, with mid-to-high-end segments such as business casual and smart casual becoming core growth drivers. The industry is accelerating its transition from 'quantity-driven competition' towards a stage of high-quality competition centered on 'innovation, quality and sustainable development. China Lilang deepened its presence in the menswear market with its differentiated brand matrix, building a diversified business portfolio through the 'LILANZ' core collection, the 'LESS IS MORE' smart casual collection and the 'MUNSINGWEAR' sports line, to comprehensively meet market demand for high-quality, diverse apparel. At the same time, the Group optimized its omni-channel marketing layout, strengthened online-offline operational synergies, actively expanded into emerging online platforms while accelerating the DTC model offline, and simultaneously advanced its internationalization strategy to enhance brand influence and operational efficiency across multiple dimensions.”During the year, the Group's revenue increased by 11.5% year-on-year to RMB4.07 billion. Revenue from the smart casual and other collections surged by 28.4%, primarily driven by a significant increase in average sales per store and the outstanding performance of new retail channels. Revenue from the core collection grew by 6.0%, mainly due to the initial operational efficiencies generated during the year following the Group's transition to a DTC model after reclaiming distribution rights from distributors starting last year.Gross profit margin increased by 1.9 percentage points year-on-year to 49.6%, mainly due to the increase in average unit price as a result of a higher proportion of direct-to-retail sales, coupled with a smaller one-off deduction from revenue arising from the recovery of distribution rights. Profit attributable to equity shareholders was RMB502 million (2024: RMB460 million), representing an increase of 9.0%. The profit margin attributable to equity shareholders decreased by 0.3 percentage points year-on-year to 12.6%. Earnings per share increased by 9.0% to RMB41.96 cents.The Board has recommended a final dividend of HK13 cents per share (2024: HK9 cents) and a special final dividend of HK3 cents per share (2024: HK3 cents). Together with the interim dividend already paid, the total dividend for the year amounted to HK32 cents per share, maintaining a stable dividend payout ratio.During the year, the Group adhered to its core strategy of ensuring a well-differentiated brand matrix and deepening its presence in the menswear market. The "LILANZ" core collection continued to consolidate its competitive advantage in the traditional menswear market. By optimizing product structure and deepening regional channel deployment and penetration, it further enhanced brand awareness and market share in key markets. Having successfully completed the repurchase and transformation of distribution rights in Northeast China and Jiangsu Province last year, the Group accelerated channel innovation throughout the year, subsequently acquiring the operating rights of first-tier distributors in Shandong Province and Chongqing City. The "LESS IS MORE" smart casual collection, targeting younger consumers, continued to operate under a fully direct-to-retail model, with its store opening strategy focused on shopping malls, which is preferred by consumers to enhance the consumer experience through a precisely tailored store image. As at the end of December 2025, there were 2,446 stores for the core collection and 371 stores for the smart casual and other collections, a total of 2,817 stores with a net increase of 44 stores.During the year, the Group continued to focus on opening stores in prime locations within premium shopping malls and outlet centers, attracting customers and boosting sales through distinctive brand-specific renovations. As at 31 December 2025, the number of stores located in shopping malls and outlet stores increased to 1,135 (31 December 2024: 1,036).The Group completed strategic transformation of its new retail business, upgrading it from an inventory clearance channel into a major new product sales platform. Revenue from this segment recorded a significant increase of 25% during the year. While continuing to strengthen its presence on mature sales platforms like Tmall, JD.com and TikTok, the Group has also expanded into emerging channels such as Pinduoduo, Wechat Channels and Poizon, creating a diversified online sales network altogether.  The Group made full use of social platforms such as Xiaohongshu and Weibo to continuously produce high-quality content to strengthen its content-driven e-commerce strategy. This approach not only deepened the emotional connection with consumers but also effectively expanded the young customer base, opening new growth opportunities for the new retail business.Regarding the "Multi-brands and Internationalization" development strategy, the premium golf apparel brand "MUNSINGWEAR", a key element of the Group's multi-brand strategy, successfully completed its transaction closing in the first half of the year. In the second half, it opened its first batch of physical stores in locations including Chongqing and Jinjiang, further enriching the Group's diversified brand portfolio and premium product lines. Meanwhile, the Group's plan to open its first store in Malaysia was successfully implemented and the first stores commissioned in May. In November, it opened the world's first "Future Retail" concept flagship store at Pavilion Bukit Jalil, a core business district in Kuala Lumpur. By the end of December 2025, 4 stores had been opened. The smooth operation of all stores not only completed the initial layout in the Southeast Asian market but also laid an important foundation for the Group’s subsequent expansion across the region.During the year, the Group adhered to its core design philosophy of "Simplicity but Not Simple", deepening proprietary research and development across its industrial chain. It implemented a core premium product strategy, focusing on fabric innovation, craftsmanship upgrades and standard-setting to strengthen its competitive advantage of "Technology-Empowered Products", while transforming its technological expertise into industry-wide reference standards.Facing a market environment where opportunities and challenges coexist, China Lilang will maintain a prudent yet optimistic stance and continue to pursue its core strategy of "Multi-brands and Internationalization". It will advance channel reforms, strengthen product innovation and enhance operational efficiency, to bolster its leading position in China's menswear industry. The Group plans for  a net increase of approximately 50 to 100 stores in 2026, with the focus remaining on premium shopping malls and outlets. At the same time, the Group will further consolidate the operating results of the regions that have transitioned and explore the possibility of rolling out the DTC model in other suitable regions to deepen market control and elevate consumer experience.In the new retail business, the Group will continue to advance its online channel layout, aiming to achieve over 15% growth in new retail sales in 2026. Through content-focused e-commerce and targeted live streaming, the Group seeks to reach more young customers and drive overall sales growth of 10%.The Group will steadily advance the business development of "MUNSINGWEAR", planning to continue expanding its physical store network in the Chinese Mainland and expanding its online sales channels to achieve online-offline synergy. In terms of international expansion, following its successful entry into the Malaysian market, the Group's company registration process in the Philippines has been completed, with business operations expected to officially commence in 2026, gradually refining its overseas channel layout.Mr. Wang Dong Xing, Chairman of China Lilang, concluded: “Looking ahead to 2026, the global geopolitical landscape remains complex and volatile, but the Chinese government continues to introduce policies and measures to promote consumption and expand domestic demand, providing support for the domestic market. Building upon the solid foundation established in 2025, China Lilang will focus on the development of its 'LILANZ' core collection and 'LESS IS MORE' smart casual collection, while deepening its new retail strategy and advancing multi-brand and overseas businesses, enabling it to advance towards a new stage of growth characterized by improvements in both quality and efficiency. It will also continue to drive R&D  innovation and strength its ESG initiatives, achieving concurrent business growth and sustainable development, striving to create stable and sustainable returns for shareholders."About China LilangChina Lilang is one of the leading PRC menswear enterprises. As an integrated fashion enterprise, the Group designs, sources and manufactures high-quality business and casual apparel for men and sells under brands of 'LILANZ' and 'LESS IS MORE' across an extensive distribution network, mainly in the PRC and overseas. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

中國利郎公佈二零二五年全年業績

香港, 2026年3月16日 - (亞太商訊 via SeaPRwire.com) - 中國利郎有限公司(「中國利郎」或「公司」,及其附屬公司,統稱「集團」;股份編號:1234)今天公佈其二零二五年全年業績。中國利郎主席兼非執行董事王冬星先生說:「二零二五年,中國內地服裝行業在宏觀經濟穩步復甦與消費市場溫和增長的背景下,整體保持基本穩定、承壓前行的發展態勢。男裝市場在消費升級大趨勢下呈現結構性分化,商務休閒、輕商務等中高端細分賽道成為增長核心動力,行業正加速從『數量競爭』邁向以『創新、品質與可持續發展』為核心的高質量競爭階段。中國利郎以差異化品牌矩陣深耕男裝市場,通過『利郎 LILANZ』主系列、『利郎 LESS IS MORE』輕商務系列及『萬星威 MUNSINGWEAR』運動線構建多元業務佈局,全方位滿足市場高品質、多元化的消費需求。同時,集團優化全渠道營銷佈局,強化線上線下協同營運,線上積極拓展新興平台、線下加速推動DTC模式,同步推進國際化佈局,多維度提升品牌影響力與營運效能。」年內,集團收入同比增長11.5%至人民幣40.7億元。其中,輕商務及其他系列收入大幅上升28.4%,主要得益於單店平均銷售額的大幅提升以及新零售渠道的突出表現。主系列收入增長6.0%,主要由於集團自去年起從分銷商收回分銷權轉以DTC模式經營後,於年內初步產生經營效益。毛利率為49.6%,同比上升1.9個百分點,主要因為直營銷售佔比上升提高平均單價,加上因收回分銷權產生的一次性收入扣除有所減少所致。權益股東應佔利潤為人民幣5.0億元(二零二四年:人民幣4.6億元),同比上升9.0%。股東應佔利潤率為12.3%,同比下降0.3個百分點。每股盈利同比上升9.0%至人民幣41.96分。董事會建議派發末期股息每股13港仙(二零二四年:9港仙)及特別末期股息每股3港仙(二零二四年:3港仙),連同已派發的中期股息,全年每股派息合共32港仙,維持穩定的派息比率。集團於年內以差異化品牌矩陣為核心戰略,深耕男裝市場。「利郎 LILANZ」主系列持續鞏固傳統男裝市場的競爭壁壘,透過優化產品結構、深化區域渠道佈局與滲透,進一步提升品牌在核心市場的認知度與市場份額。繼去年完成東北地區及江蘇省的分銷權回購轉制後,集團於年內加速推進渠道革新,再完成收回山東省及重慶市一級分銷商的經營權。針對年輕消費者的「利郎 LESS IS MORE」輕商務系列繼續以全直營模式經營,開店策略集中在消費者偏好的購物中心,以精準的門店形象提升消費體驗。截至二零二五年十二月底,主系列門店共2,446家,輕商務及其他系列門店371家,整體共2,817家門店,淨增加44家。年內,集團繼續集中在優質購物中心中的優越鋪位和奧特萊斯開店,通過最具品牌個性的裝修吸引顧客,提升銷售。於二零二五年十二月三十一日,購物中心店及奧特萊斯店增加至1,135家(二零二四年十二月三十一日:1,036家)。集團新零售業務完成戰略轉型,從過往的庫存清理渠道升級為主力新品銷售平台,年內收入錄得25%的顯著增長。集團持續深耕天貓、京東、抖音等成熟銷售平台的同時,拓展了拼多多、微信視頻號、得物等新興渠道,形成多元化線上銷售網絡。集團同時利用小紅書、微博等社交平台,持續輸出高品質內容,強化內容電商佈局,不僅深化了與消費者的情感聯結,更有效拓展了年輕客群,為新零售業務打開新的增長空間。「多品牌、國際化」發展戰略方面,高端高爾夫服飾品牌「萬星威 MUNSINGWEAR」作為集團多品牌戰略的關鍵佈局,上半年完成交易交割後,下半年在重慶及晉江等地開設首批實體門店,進一步豐富了集團的多元化品牌組合與高端產品線。而集團在馬來西亞開設首家門店的計劃順利落實,並於五月份順利試業。十一月於吉隆坡核心商圈Pavilion Bukit Jalil開設全球首家「未來商業(Future Retail)」概念旗艦店。於二零二五年十二月底已經開設4家門店,所有門店的順利營運,不僅完成了東南亞市場的初步佈局,更為集團後續輻射東南亞市場奠下重要基礎。年內,集團貫徹「簡約不簡單」的設計核心,深化全產業鏈自主研發,打造核心精品單品戰略,專注面料創新、工藝升級與標準制定,加強「技術賦能產品」的競爭優勢的同時更將自身技術積累轉化為全行業可參照的規範標準。面對機遇與挑戰並存的市場環境,中國利郎將保持審慎樂觀的態度,繼續深耕「多品牌、國際化」核心戰略,推進渠道改革、強化產品創新、提升運營效率,鞏固並提升集團於中國男裝行業的領先地位。集團計劃於二零二六年全年淨增加約50至100家門店,開店重點繼續聚焦於優質購物中心及奧特萊斯。同時,集團將進一步鞏固已轉型區域的經營成果,並探索在更多合適區域推廣DTC模式,以強化市場控制力、提升消費體驗。新零售業務方面,集團將持續推進線上渠道佈局,目標二零二六年實現新零售銷售額增長15%以上,並通過內容電商與精準直播觸達更多年輕客群,帶動整體銷售實現10%增長。集團將穩步推進「萬星威 MUNSINGWEAR」的業務發展,計劃在中國內地繼續拓展實體門店網絡,並拓展線上銷售渠道,實現線上線下聯動。國際化拓展方面,繼馬來西亞市場後,集團在菲律賓的公司註冊程序已完成,預計於二零二六年內正式開展業務,逐步完善海外渠道佈局。王冬星主席總結說:「展望二零二六年,全球地緣政治格局依然複雜多變,但中國政府持續推出促進消費、擴大內需的政策措施,為國內市場提供支撐。中國利郎將立足於二零二五年所奠定的穩健基礎,在聚焦『利郎 LILANZ』主系列及『利郎LESS IS MORE』輕商務發展的同時,深化新零售戰略,推進多品牌及海外業務,從而向質量與效率雙升的高階增長階段邁進,並將繼續透過研發創新,持續加強 ESG 建設,實現業務增長與可持續發展並行,致力為股東創造穩健及可持續的回報。」關於中國利郎中國利郎是中國領先的男裝企業之一。作為一家綜合時裝企業,集團設計、採購、生產並以品牌「利郎LILANZ」及「利郎LESS IS MORE」銷售優質男士商務及休閒服裝。其產品主要於中國及海外的廣闊零售及分銷網絡銷售。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management

Kawasaki and Tokyo, Japan, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Japan Limited and Teikyo University Hospital today announced the start of a joint proof of concept aimed at strengthening regional medical collaboration. The initiative, which commenced on March 16, focuses on developing new information analysis and patient management mechanisms utilizing medical administration systems and electronic health record data. This will facilitate the prompt admittance of severely ill patients requiring hospitalization or surgery and a smooth transition back to primary care after discharge.This joint experiment will implement the following initiatives for Teikyo University Hospital's regional medical collaboration operations:1. Digitalization of Patient Workflow from Referral Acceptance to Discharge CoordinationBy introducing AI-OCR and electronic paper for referral reception and discharge coordination, information from outside the hospital will be digitized. This will be seamlessly integrated with electronic health records and regional medical collaboration information systems, aiming to eliminate duplicate data entry and improve overall operational efficiency.2. Verification of the Health Care Management Platform for Data-Driven Strategic Patient AcquisitionBased on data from medical accounting systems and electronic health records, Health Care Management Platform, an offering under Fujitsu Limited's Uvance business model which addresses societal challenges, will be used to visualize and analyze trends in referred patients and collaborating facilities in a timely manner. This will enable the identification of facilities where collaboration should be strengthened, and actual visits to these facilities will be conducted to enhance regional collaboration. Visit records and results will be registered and accumulated in Salesforce's Agentforce 360 Platform, aiming to utilize this information for analyzing referral performance and formulating strategies that comprehensively address the needs of collaborating facilities.Figure: Patient workflow in regional medical collaboration and a joint proof of conceptThrough this initiative, Teikyo University Hospital aims to reduce the administrative workload of its Medical Collaboration Office, which handles regional collaboration tasks, by 30%, while contributing to the provision of high-quality and prompt medical care and the optimization of medical resources for patients.Moving forward, both parties will expand the scope of integration between this system and electronic health records to centrally manage the patient workflow, including treatment processes after referral acceptance. This will contribute to providing medical care to patients at more appropriate times and supporting decision-making for healthcare professionals, thereby improving hospital management and fostering regional medical collaboration.Fujitsu Japan will leverage the insights from this joint experiment to enhance accuracy and add new functionalities to its offerings, supporting Teikyo University Hospital's digital transformation (DX) and the promotion of digital hospitals. Furthermore, under Uvance, Fujitsu Japan will drive the transformation of medical practice workflows through data and AI, advancing the establishment of a sustainable healthcare delivery system.Teikyo University Hospital will systematize this mechanism as a model for realizing a data-driven regional healthcare system and promote its expansion to other medical institutions and regions. Through this initiative, the hospital also aims to further enhance the role and value of its Medical Collaboration Office, which serves as the hospital's public face, and build a foundation for the office to function as a hub for regional medical care, moving beyond its traditional role of handling referral reception and coordination.BackgroundJapanese healthcare faces a challenging management environment due to a declining birthrate, an aging population, and rising material costs, while medical needs are becoming increasingly complex due to advancements in medical technology. To ensure sustainable healthcare, it is essential to strengthen collaboration between primary care physicians and specialists, ensuring patients are referred at appropriate times, receive advanced treatment, and are then referred back to their primary care physicians for ongoing care. This kind of regional medical collaboration is essential.The Japanese government is also promoting medical DX and functional differentiation and collaboration within regions, establishing evaluations and incentives in the fiscal year 2026 medical fee revision.As a specialized hospital in the Itabashi Ward region, Teikyo University Hospital accepts over 30,000 referred patients annually and has actively promoted regional collaboration through continuous lectures and visits to medical institutions. Regarding referred patient acceptance, the hospital receives approximately 200 calls daily from patients and medical institutions, utilizing up to eight lines at a time. A key challenge has been the time and burden placed on reception staff to coordinate referred patient acceptance, especially for urgent referrals and transfer requests from other medical institutions, often requiring consultation with doctors, leading to waiting times for outpatient appointments and hospitalization.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Accelerated Technology Commercialization Drives High-Growth Performance, Qunabox Group Leads the AI Interactive Marketing Track

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – As the integration of artificial intelligence technology with physical consumption scenarios enters a deeper stage, a dual revolution in business efficiency and consumer experience is unfolding. As a leader in China’s AI interactive marketing services sector, Qunabox Group (00917.HK) has achieved both rapid performance growth and a turnaround to profitability by leveraging its innovative business model of "technology middleware platform + multi-business synergy + global scenario deployment", setting a new benchmark for the digital transformation of the industry.AI-Powered Marketing Services, Building a Dual-Engine Model of "Technology + Data"At the core of Qunabox Group’s business model is the creation of a technology-driven, end-to-end value closed loop that upgrades AI from a single functional tool to a core engine embedded throughout the entire consumer journey. Marketing services, as the Group’s core business segment, has developed a dual-engine model of "standardization + value-added services", which continuously optimizes revenue quality and gross profit structure.In terms of service model, the Group has deeply covered key consumer sectors such as food and beverages, daily necessities, new energy vehicles and household appliances. With a high-quality, stable and diversified brand customer base as its foundation, the Group keeps deepening cooperation with major clients by expanding service scenarios and optimizing product portfolio, thus achieving simultaneous growth in both the number of clients and the value generated per client.In terms of product innovation, the Group takes technological R&D as the key driver, enabling AI to act as the "execution agent" throughout the end-to-end marketing value chain. The upgraded AI digital human shopping assistant, equipped with cross-sensory intent recognition and high-precision 3D modeling, delivers precise personalized recommendations and elevates user experience. The newly launched AI holographic marketing cabinet creates immersive display scenarios for high-intelligence products, restructuring the interaction mode of offline marketing. Meanwhile, the AI Agent marketing workstation enables closed-loop management across the entire process from content planning to performance tracking, raising marketing execution efficiency and precision to a new level.In the meantime, the implementation of the AIGC marketing resource library and the marketing selling points database for beverages and snack foods has made data value the core support for marketing decision-making, forming a new marketing service model driven by the dual wheels of "technology + data" and further consolidating the Group’s leading position in the field of AI interactive marketing.Global Layout in Innovative Tracks, R&D Innovation to Build Solid BarriersLifestyle and innovative businesses have injected long-term growth momentum into the Group’s business model. Focusing on "AI + Lifestyle", the Group has proactively explored emerging markets, with key focus on the Middle East, Southeast Asia and Australia where the demand for high-quality technology-enabled experiential consumption is robust. An overseas business department has been established to achieve end-to-end localized operation and management. At present, the AI indoor entertainment space has completed preliminary preparation and successfully obtained relevant business licenses in Dubai and Singapore.From the validation of localized models to the integration of software and hardware systems, and from the building of professional teams to the development of content ecosystem, the Group has realized cross-cultural and multilingual adaptation of its AI technologies through refined operation and management. This has allowed its "AI + consumption scenarios" business model to expand beyond domestic markets, providing innovative solutions for the upgrading of global consumer markets.In addition, other service businesses including IT system development leverage the Group’s technological reserves and first-mover advantages in AI applications to undertake technology development demands from industrial clients. These businesses have become an important extension of the commercialization of the Group’s technological capabilities, further enriching the Group’s revenue structure.In building technological barriers, Qunabox Group deeply integrates R&D innovation with intellectual property protection. The number of software copyrights registered in China and patents held by the Group has increased to 173 and 22 respectively, with an additional 133 patents currently under application, making technological innovation a solid guarantee for the sustainable development of the Group’s business model.At present, the integration of artificial intelligence and physical consumption is entering a phase of accelerated large-scale implementation. With its business model centered on "AI + Consumption Scenarios", Qunabox Group has not only achieved high-quality development for itself, but also reshaped the value creation model of the consumer industry.Looking ahead, Qunabox Group will continue to deepen its technological advantages and service capabilities, advance strategic industrial mergers and acquisitions, and optimize its AI-powered experiential consumption business model. By leveraging the synergy of new technologies, new scenarios and new markets, the Group aims to build a cross-regional, end-to-end AI lifestyle platform. It will keep driving industry innovation and progress, creating commercial value for brand clients, delivering new experiences for consumers, and generating long-term value for shareholders and society. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

富衛集團2025年全年業績創新高 實現盈利增長及資本與現金流創造能力提升

香港, 2026年3月16日 - (亞太商訊 via SeaPRwire.com) - 富衛集團有限公司(「富衛集團」或「富衛」)今日公布截至2025年12月31日的年度業績,是在香港上市後的首份全年業績。- 新增業務銷售額按年化新保費計算較2024年上升25% 至24.46億美元。新業務合約服務邊際為14.76億美元,按年增長18%。- 稅後營運利潤增長5%,達4.99億美元。香港特別行政區和澳門特別行政區、泰國和柬埔寨、日本以及新興市場四個地區業務分部皆為集團帶來正面貢獻。- 淨利潤達1.66億美元,自《國際財務報告會計準則》第17號實施後,連續第二年創新高。截至2025年12月31日,富衛集團實現正營運現金流。槓桿比率降至21.3%,接近富衛訂立的15%至20%的目標範圍。- 創造股東價值的重要指標大幅提升,綜合有形權益較2024年12月31日上升18%至87.2億美元;集團內涵價值按年增長19%至68.5億美元。償付能力比率保持穩健,達265%^。- 2025年12月,富衛集團獲納入恒生綜合指數,並被列入滬深港通的合資格股份名單,透過該機制,內地投資者可經由上海及深圳證券交易所以南向交易安排投資香港市場。2026年2月,富衛集團亦獲納入MSCI香港小型股指數。富衛集團行政總裁兼執行董事黃清風表示:「2025 年對富衛集團而言意義非凡。我們成功推行以客為先的策略,並憑藉數碼化營運模式,創下破紀錄的財務業績。我們於2025年7月成功完成首次公開招股,正式成為上市公司,達成了我們長期以來的目標,使富衛得以全面進入資本市場,為未來的發展和增長奠定穩固的基礎。」富衛集團2025年的強勁業績主要由其10個亞洲市場中大部分市場的有機增長所帶動,其中香港特別行政區及澳門特別行政區分部的表現最為突出。日本分部亦錄得穩健表現,在成功的保障業務基礎上,開始拓展退休及儲蓄領域,並推出首款日圓整付保費年金產品。富衛是泰國的市場領導者,儘管2025年業績受利率下行環境影響,以及2024年退出承保企業醫療新業務,泰國分部仍保持穩健地位,為未來優質新業務增長奠定堅實基礎。新興市場分部(涵蓋富衛集團東南亞其餘五個市場)錄得卓越增長,受惠於該地區長期的人口結構、財富累積及數碼化採用趨勢。黃清風補充道:「踏入2026 年,我們將堅定不移地執行既定策略,着眼未來發展,秉持以客為先的理念,深耕高速增長的亞洲市場,並持續聚焦長期可持續發展及盈利能力。」關於富衛集團富衛集團(香港聯合交易所上市代號:1828)為泛亞洲人壽及健康保險公司,服務超過3,800萬名客戶,業務遍及亞洲十個市場,包括印尼人民銀行人壽保險(BRI Life)。富衛秉持以客為先的方針及科技賦能的模式,致力為客戶帶來創新定位、簡單易明的產品和簡單的保險體驗。自2013年成立以來,富衛於部分全球發展最迅速的保險市場營運業務,專注為大眾創造保險新體驗。富衛集團在香港聯合交易所有限公司主板上市,股份代號為1828。如欲了解更多資訊,請瀏覽www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings Limited所有業績數據均截至 2025年12月31日並與2024年同期比較。集團當地資本總和法覆蓋率、集團內涵價值、綜合有形權益為2025年12月之結餘/比率和增長率。增長率按固定匯率計算,除非另有說明。稅後營運利潤/(虧損)(非國際財務報告會計準則計量指標)、淨利潤/(虧損)及綜合有形權益外,其他數據均未經審計師審核。稅後營運利潤及稅後淨利潤為公司權益持有人應佔部分,並已扣除非控股權益。新增業務銷售以年化新保費100%及整付保費10%組合計算。綜合有形權益按本公司股東應佔本集團權益總額加合約服務邊際結餘(扣除稅項及非控股權益),減無形資產(扣除非控股權益)計算。*按實際匯率計算^按訂明資本要求基準計算 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation

HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its first set of full-year results as a Hong Kong listed company for the 12 months ended 31 December 2025.- New business sales were up 25 per cent to US$2.446 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) was US$1.476 billion, with year-on-year growth of 18 per cent.- Operating profit after tax was up five per cent to US$499 million with positive contributions from each of the company’s four geographic reporting segments – Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$166 million is a record IFRS 17 result and for the second consecutive year, FWD Group was operating cash flow positive as at 31 December 2025. Leverage ratio reduced to 21.3 per cent approaching the company’s target range of 15-20 per cent.- Significantly increased important indicators of shareholder value creation, with comprehensive tangible equity (CTE) up 18 per cent to US$8.72 billion compared to 31 December 2024 and Group embedded value (EV) up 19 per cent year-on-year to US$6.85 billion. A strong capital position was maintained with a 265 per cent solvency ratio^.- In December 2025, FWD Group was added to the Hang Seng Composite Index and the eligible securities list for the Stock Connect programme, where Mainland Chinese investors connect via the Shanghai Stock Exchange and Shenzhen Stock Exchange with Hong Kong market opportunities via a southbound trading mechanism. FWD Group was also included in the MSCI Hong Kong Small Cap Index in February 2026.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “2025 was a stand-out year for FWD Group. We successfully executed our customer-led strategy, underpinned by our digitally enabled business model. Record financial results were achieved. And of course, we began trading as a publicly listed company, following our July 2025 initial public offering. This fulfilled a long-held objective to ensure FWD Group has full capital market access, as a solid foundation for our future development and growth.”The strong 2025 results were driven by organic growth across most of the 10 Asian markets where FWD Group operates, with a particularly outstanding performance in the Hong Kong SAR & Macau SAR segment.A solid performance was posted in Japan, in a year where FWD began to diversify beyond its successful protection business into the retirement and savings segment, with its first offering – a yen-denominated single premium variable annuity product.As an established market leader in Thailand, FWD remains well positioned to grow quality new business in future, despite headwinds from a lower rate environment which impacted 2025 results, in addition to the 2024 exit from underwriting new business in the corporate care segment.Excellent growth was delivered in the Emerging Markets segment – which is comprised of five of the rest of FWD Group’s Southeast Asian markets – consistent with the longer-term demographic, wealth creation, and digital adoption trends in this region.“With 2026 already underway, we remain firmly focused on executing our strategy as we build for the future – operating with customers at the heart of everything we do in high-growth Asian markets, with a focus on long-term sustainability and profitability,” added Huynh Thanh Phong.About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves more than 38 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828.For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings LimitedThe results are for the 12 months ended 31 December 2025 and are compared to the same period in 2024.Group LCSM cover ratio, group embedded value, comprehensive tangible equity values are December 2025 balances/ratios and growth rates are represented accordingly.Growth rates are represented on a constant exchange rate (CER) basis, unless otherwise stated.Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Comprehensive tangible equity is calculated as total equity of the Group attributable to shareholders of the Company plus contractual service margin (net of tax and non-controlling interests), minus intangible assets (net of non-controlling interests).* Actual exchange rate basis  ^ Prescribed capital requirement (PCR) basis Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com